Fresh Tracks Therapeutics, Inc. (FRTX)

Fresh Tracks Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	6	5	4	18	19	5
Market Cap Growth	15.11%	23.40%	-77.20%	-3.39%	321.68%	-82.41%
Enterprise Value	-5	-6	-4	-8	-10	-3
PE Ratio	-	-0.91	-0.20	-0.47	-0.91	-0.17
PS Ratio	0.71	0.65	0.61	45.72	10.49	0.57
PB Ratio	0.57	0.52	0.59	0.74	0.70	0.60
P/FCF Ratio	-1.20	-1.20	-0.22	-0.51	-0.95	-0.13
P/OCF Ratio	-1.20	-1.20	-0.22	-0.51	-0.95	-0.13
EV/Sales Ratio	-0.71	-0.71	-0.64	-20.65	-5.75	-0.32
EV/EBITDA Ratio	0.98	1.00	0.21	0.21	0.50	0.10
EV/EBIT Ratio	0.97	1.00	0.21	0.21	0.50	0.10
EV/FCF Ratio	1.31	1.31	0.23	0.23	0.52	0.07
Debt / Equity Ratio	0	0	0.01	0.00	0.02	0.02
Debt / EBITDA Ratio	-	-	0.00	0.00	-0.02	-0.01
Debt / FCF Ratio	-	-	0.00	0.00	-0.03	0.00
Quick Ratio	6.59	6.59	2.98	5.62	4.74	1.12
Current Ratio	6.98	6.98	3.28	6.15	5.28	1.71
Asset Turnover	0.61	0.69	0.68	0.01	0.05	0.44
Interest Coverage	0	-1272.00	-2392.67	-583.25	0	-11.67
Return on Equity (ROE)	-56.72%	-57.34%	-287.20%	-158.67%	-77.03%	-342.55%
Return on Assets (ROA)	-48.61%	-49.15%	-201.16%	-132.99%	-62.15%	-142.99%
Return on Capital (ROIC)	-64.05%	-64.05%	-297.31%	-161.13%	-75.87%	-316.74%
Earnings Yield	-99.25%	-109.54%	-490.51%	-213.94%	-109.32%	-572.17%
FCF Yield	-76.53%	-83.55%	-460.15%	-195.88%	-104.89%	-793.65%
Buyback Yield / Dilution	-96.23%	-110.56%	-57.33%	-227.63%	-710.92%	3.12%
Total Shareholder Return	-96.23%	-110.56%	-57.33%	-227.63%	-710.92%	3.12%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.